News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,021 Results
Type
Article (45824)
Company Profile (354)
Press Release (694832)
Multimedia
Podcasts (129)
Webinars (18)
Section
Business (208522)
Career Advice (2042)
Deals (36102)
Drug Delivery (126)
Drug Development (84412)
Employer Resources (175)
FDA (16968)
Job Trends (15209)
News (354132)
Policy (33482)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2703)
Academic (1)
Accelerated approval (37)
Adcomms (32)
Allergies (147)
Alliances (50939)
ALS (177)
Alzheimer's disease (1750)
Antibody-drug conjugate (ADC) (345)
Approvals (17190)
Artificial intelligence (550)
Autoimmune disease (173)
Automation (42)
Bankruptcy (366)
Best Places to Work (11853)
BIOSECURE Act (23)
Biosimilars (199)
Biotechnology (237)
Bladder cancer (165)
Brain cancer (65)
Breast cancer (674)
Cancer (5073)
Cardiovascular disease (438)
Career advice (1726)
Career pathing (36)
CAR-T (315)
CDC (49)
Celiac Disease (2)
Cell therapy (847)
Cervical cancer (37)
Clinical research (71925)
Collaboration (1833)
Company closure (4)
Compensation (1206)
Complete response letters (72)
COVID-19 (2798)
CRISPR (103)
C-suite (902)
Cystic fibrosis (153)
Data (6409)
Decentralized trials (2)
Denatured (31)
Depression (148)
Diabetes (524)
Diagnostics (6835)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (271)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (248)
Earnings (91207)
Editorial (63)
Employer branding (21)
Employer resources (154)
Events (120592)
Executive appointments (1009)
FDA (20167)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1547)
Gene editing (218)
Generative AI (46)
Gene therapy (688)
GLP-1 (1056)
Government (4799)
Grass and pollen (6)
Guidances (384)
Healthcare (19392)
HIV (67)
Huntington's disease (50)
IgA nephropathy (84)
Immunology and inflammation (281)
Immuno-oncology (64)
Indications (116)
Infectious disease (3080)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (259)
Interviews (318)
IPO (16890)
IRA (52)
Job creations (3708)
Job search strategy (1440)
JPM (67)
Kidney cancer (17)
Labor market (86)
Layoffs (591)
Leadership (34)
Legal (8057)
Liver cancer (96)
Longevity (15)
Lung cancer (682)
Lymphoma (389)
Machine learning (44)
Management (59)
Manufacturing (841)
MASH (176)
Medical device (14029)
Medtech (14086)
Mergers & acquisitions (20307)
Metabolic disorders (1366)
Multiple sclerosis (166)
NASH (18)
Neurodegenerative disease (353)
Neuropsychiatric disorders (96)
Neuroscience (3060)
Neurotech (1)
NextGen: Class of 2026 (6728)
Non-profit (4618)
Now hiring (68)
Obesity (654)
Opinion (283)
Ovarian cancer (169)
Pain (214)
Pancreatic cancer (238)
Parkinson's disease (299)
Partnered (34)
Patents (517)
Patient recruitment (516)
Peanut (58)
People (60047)
Pharmaceutical (78)
Pharmacy benefit managers (29)
Phase 1 (22464)
Phase 2 (31601)
Phase 3 (23592)
Pipeline (5505)
Policy (307)
Postmarket research (2723)
Preclinical (9552)
Press Release (69)
Prostate cancer (252)
Psychedelics (58)
Radiopharmaceuticals (303)
Rare diseases (933)
Real estate (6064)
Recruiting (72)
Regulatory (25254)
Reports (53)
Research institute (2503)
Resumes & cover letters (355)
Rett syndrome (28)
RNA editing (19)
RSV (82)
Schizophrenia (154)
Series A (256)
Series B (202)
Service/supplier (12)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (167)
Sponsored (43)
Startups (3754)
State (2)
Stomach cancer (20)
Supply chain (105)
Tariffs (89)
The Weekly (96)
Vaccines (1059)
Venture capital (94)
Weight loss (434)
Women's health (94)
Worklife (19)
Date
Today (150)
Last 7 days (585)
Last 30 days (2396)
Last 365 days (30999)
2026 (3951)
2025 (31277)
2024 (36308)
2023 (41052)
2022 (52297)
2021 (56827)
2020 (55098)
2019 (47636)
2018 (35957)
2017 (33034)
2016 (32438)
2015 (38445)
2014 (32164)
2013 (27177)
2012 (29331)
2011 (30045)
2010 (28196)
Location
Africa (765)
Alabama (84)
Alaska (7)
Arizona (315)
Arkansas (13)
Asia (40685)
Australia (6729)
California (11569)
Canada (3334)
China (1170)
Colorado (490)
Connecticut (494)
Delaware (343)
Europe (89866)
Florida (1743)
Georgia (370)
Hawaii (3)
Idaho (62)
Illinois (890)
India (71)
Indiana (531)
Iowa (23)
Japan (444)
Kansas (131)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1409)
Massachusetts (8404)
Michigan (328)
Minnesota (637)
Mississippi (5)
Missouri (139)
Montana (33)
Nebraska (28)
Nevada (122)
New Hampshire (83)
New Jersey (3075)
New Mexico (32)
New York (3076)
North Carolina (1552)
North Dakota (10)
Northern California (5640)
Ohio (341)
Oklahoma (22)
Oregon (42)
Pennsylvania (2335)
Puerto Rico (24)
Rhode Island (48)
South America (1133)
South Carolina (67)
South Dakota (1)
Southern California (4485)
Tennessee (180)
Texas (1794)
United States (41243)
Utah (342)
Vermont (1)
Virginia (268)
Washington D.C. (84)
Washington State (937)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
741,021 Results for "biorestorative therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioRestorative Announces Closing of $5.0 Million Public Offering
February 15, 2026
·
5 min read
Press Releases
BioRestorative Announces Pricing of $5.0 Million Public Offering
February 12, 2026
·
5 min read
Press Releases
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
February 11, 2026
·
6 min read
Press Releases
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
October 16, 2025
·
4 min read
Press Releases
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
·
8 min read
Press Releases
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
February 10, 2026
·
7 min read
Press Releases
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
November 5, 2025
·
4 min read
Press Releases
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
October 7, 2025
·
6 min read
Pharm Country
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will participate at the Jefferies Global Healthcare Conference being held June 5-6, 2024 at the Marriot Marquis in New York.
June 4, 2024
·
3 min read
Press Releases
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
August 13, 2025
·
7 min read
1 of 74,103
Next
